What Is Revolution Medicines’s NPS Score?
Revolution Medicines (RVMD) has a Net Promoter Score (NPS) of 0, an estimate based on anonymous customer surveys aggregated by AltIndex. A negative NPS means Revolution Medicines has more detractors than promoters. Sustained customer dissatisfaction typically leads to weaker retention, negative word-of-mouth, and revenue pressure.
The score has held broadly steady since last month.
What Is a Net Promoter Score?
NPS is calculated by asking customers how likely they are to recommend a company on a 0–10 scale. Respondents scoring 9–10 are Promoters, 7–8 are Passives, and 0–6 are Detractors. The score is the percentage of Promoters minus the percentage of Detractors, giving a result from -100 to 100.
As a rule of thumb, above 0 is positive, above 30 is strong, above 50 is excellent, and above 70 is world-class — only a handful of companies consistently clear 70. Revolution Medicines’s NPS of 0 is below average.
Why NPS Matters for RVMD Investors
NPS can be a leading indicator of revenue retention and pricing power: loyal customers spend more, churn less, and cost less to keep, so brands with high and rising NPS tend to grow faster and defend margins better. AltIndex feeds Revolution Medicines’s NPS into the RVMD AI Score as one of 25+ alternative data signals.
For other brand and customer signals, see Revolution Medicines’s Instagram followers, Google Trends, web traffic, and app downloads — or the employee-side view in employee business outlook.
Month over Month
| Oct 2025 | 46 | |
| Jul 2025 | 41 | |
| Dec 2024 | 36 | |
| Nov 2024 | 50 | |
| Sep 2024 | 44 |
Revolution Medicines NPS: Frequently Asked Questions
Revolution Medicines’s Net Promoter Score is 0, which is below average. NPS ranges from -100 to 100 and is the percentage of promoters minus the percentage of detractors. This is an estimate based on anonymous customer surveys aggregated by AltIndex.
NPS ranges from -100 to 100. Above 0 is positive (more promoters than detractors), above 30 is strong, above 50 is excellent, and above 70 is world-class — only a handful of companies consistently score above 70. Revolution Medicines’s NPS of 0 is below average.
Revolution Medicines’s NPS has held broadly steady since last month. The trend chart above shows the full history.
No single signal predicts a stock on its own, but NPS can be a leading indicator: high customer loyalty is linked to lower churn, stronger pricing power, and higher customer lifetime value, which tend to support faster growth. AltIndex tracks NPS as one of 25+ signals in the RVMD AI Score, alongside web traffic, social audience, and insider activity.
Companies rarely disclose an official NPS, so AltIndex publishes an estimated NPS aggregated from anonymous customer surveys. It is calculated the standard way — the share of promoters (customers who would recommend the brand) minus the share of detractors — on a scale from -100 to 100, and it is updated regularly.
Sign up and get more insights on Revolution Medicines.
See Revolution Medicines’s complete nps history
Sign up to unlock 1-year and all-time charts for RVMD — plus 25+ alternative data signals, AI Scores, and real-time alerts.
Sign up
